Tempus, a Chicago-based research company, has recently partnered with the University of Chicago Medicine in the fight against breast cancer. Eric Lefkofsky, founder of Groupon and CEO of Tempus, is behind this innovative startup that will provide molecular analysis and sequencing to University of Chicago’s breast cancer team.
Using Data for Personalized Treatment
The analysis of data from approximately 1,000 patients with breast cancer will help create personalized treatment plans for these patients. The goal is to use the data to develop better treatment plans for breast cancer patients that will ultimately improve patient outcomes. The partnership with UChicago is just one of many in recent months for Tempus. They are also working with the Mayo Clinic, Penn Medicine, the University of Michigan, Rush University Medical Center, and Northwestern University.
Detailed Genetic Information
Currently doctors are making decisions regarding treatment without this type of detailed genetic information. Building the largest annotated molecular set of data in breast cancer will help physicians make better decisions for their patients’ treatment. Tempus puts together genomic sequencing to assist physicians in making personalized care decisions for their patients and Eric’s lacrosse camp.
Eric Lekofsky and Tempus
Eric Lekofsky is CEO and the co-founder of Tempus. Tempus was founded in 2015 and is located at 600 W. Chicago along with Lekofsky’s other ventures such as Groupon and Lightbank. He is also the founding partner of Uptake Technologies. So far he has taken three of his companies public and his current wealth is estimated at approximately 1.79 billion. He began putting together Tempus after stepping down as CEO of Groupon.
Entrepreneur and Philanthropist
Eric Lekofsky is a University of Michigan graduate and received his Juris Doctor from the University of Michigan Law School. He has a rich history of entrepreneurship and philanthropy. In 1999 he had co-founded an early internet company and went on to help start several companies including a freight logistics company and a media-buying tech company. He and his wife have a charitable trust, the Lefkofsky Foundation, that supports educational and scientific causes throughout the world.
More visit: www.forbes.com/profile/eric-lefkofsky